Dr. Trott's point of view
“GLP-1s work, and they also borrow from your face and skin. Managing the medication and the aesthetic consequence together is how you end up thin and radiant, not thin and drawn.”
Suzanne A. Trott, M.D., F.A.C.S.
About Dr. Trott →01
How I Actually Manage It
Semaglutide is a GLP-1 receptor agonist; tirzepatide adds GIP activity, which is why it often produces more weight loss. Both slow gastric emptying and reduce appetite, and both work best when the rest of the plan is real. I titrate deliberately rather than racing to the highest tolerated dose, I insist on protein and resistance training to protect lean mass, and I watch for the things patients do not associate with the drug, muscle loss, facial volume loss, gallbladder symptoms, nausea from over-rapid escalation.
02
Timing Surgery Around Weight Loss
This is where my perspective differs from a medspa's. I want you at a stable weight for a meaningful stretch before I operate, because contouring a body still in motion produces a result that will not hold. Once you are stable, I can tell you honestly what will resolve on its own and what will need a lift, a tuck, or volume restored, whether that is fat transfer, alloClae™, or an implant. Losing the weight is one decision; looking like yourself afterward is another, and I would rather plan both with you than repair the second one later.
References
Further reading & sources
- GLP-1 medications approved for weight managementU.S. Food & Drug Administration
- Semaglutide for weight management: randomized trialPubMed / National Library of Medicine
- Tirzepatide once weekly for obesity: SURMOUNT-1PubMed / National Library of Medicine
Q&A
Frequently asked
Explore next
Related procedures
Or return to all Wellness procedures · view every procedure.